Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Apr 29, 2004
app pub date -
Nov 26, 2002
filing date -
Mar 11, 1998
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Novel methods of medical treatment and/or inhibition of development of diseases are disclosed for diseases that are sensitive to androgenic or estrogenic activity. The treatments utilize inhibitors of type 5 and/or type 3 17.beta.-hydroxysteroid dehydrogenase. Novel inhibitors of type 5 17.beta.-hydroxysteroid dehydrogenase are also disclosed, as are novel inhibitors of type 3 17.beta.-hydroxysteroid dehydrogenase.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully